U.S. District Judge Matthew Maddox issued a preliminary order on Sept. 5 blocking program 340B, according to court documents obtained by Becker’s. The judge’s written order did not explain his reasoning but referred to the statements he made from the bench during a hearing held Sept. 4.
Drug companies Pharmaceutical Research and Manufacturers of America, Novartis, AbbVie and AstraZeneca had sought to prevent the law from taking effect, arguing that the 340B conflicts with federal regulations.
The case is one of numerous similar challenges to state laws dealing with companies’ federal obligations under the 340B program.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
